CCL2 and obesity due to melanocortin 4 receptor deficiency: Further, a VLCKD improves inflammation, reducing TNF-alpha, PAI-1, IL-6, IL-8 and MCP-1, which are strongly involved in the pathophysiology of cardiovascular diseases and obesity [41].